Septal reduction therapiescibenzolineBeta blockersJapanese Hypertrophic Cardiomyopathy Registry Studyhypertrophic cardiomyopathyHOCM
…d to 90% of patients with HOCM, while 51% received cibenzoline. Septal reduction therapies were performed in 22% of patients with HOCM, with 6% undergoing…